0001209191-13-031238.txt : 20130607 0001209191-13-031238.hdr.sgml : 20130607 20130607175226 ACCESSION NUMBER: 0001209191-13-031238 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130604 FILED AS OF DATE: 20130607 DATE AS OF CHANGE: 20130607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0000786947 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 110853640 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 CITY: PALATINE STATE: IL ZIP: 60067 BUSINESS PHONE: 847-705-7709 MAIL ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 STREET 2: . CITY: PALATINE STATE: IL ZIP: 60067 FORMER COMPANY: FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GALEN PARTNERS III L P CENTRAL INDEX KEY: 0001034486 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 13901711 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVE STREET 2: 5TH FL CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 2122184990 MAIL ADDRESS: STREET 1: 610 FIFTH AVE STREET 2: 5TH FL CITY: NEW YORK STATE: NY ZIP: 10020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Galen Management, LLC CENTRAL INDEX KEY: 0001421162 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 13901712 BUSINESS ADDRESS: BUSINESS PHONE: 203 654 6400 MAIL ADDRESS: STREET 1: 680 WASHINGTON BLVD CITY: STAMFORD STATE: CT ZIP: 06901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GALEN EMPLOYEE FUND III LP CENTRAL INDEX KEY: 0001056642 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 13901713 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 2122184990 MAIL ADDRESS: STREET 1: 610 FIFTH AVENUE 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GALEN PARTNERS INTERNATIONAL III L P CENTRAL INDEX KEY: 0001034574 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 13901714 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE 5TH FLOOR STREET 2: C/O GALEN ASSOCIATES CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 2122184990 MAIL ADDRESS: STREET 1: 610 FIFTH AVENUE 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLAUDIUS LLC CENTRAL INDEX KEY: 0001056643 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 13901715 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE 5TH FLOOR STREET 2: C/O GALEN ASSOCIATES CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 2122184990 MAIL ADDRESS: STREET 1: C/O GALEN ASSOCIATES STREET 2: 610 FIFTH AVENUE 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10020 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-06-04 0 0000786947 ACURA PHARMACEUTICALS, INC ACUR 0001056643 CLAUDIUS LLC C/O GALEN MANAGEMENT, L.L.C. 680 WASHINGTON BLVD. STAMFORD CT 06901 0 0 1 0 0001034574 GALEN PARTNERS INTERNATIONAL III L P C/O GALEN MANAGEMENT, L.L.C. 680 WASHINGTON BLVD. STAMFORD CT 06901 0 0 1 0 0001056642 GALEN EMPLOYEE FUND III LP C/O GALEN MANAGEMENT L.L.C. 680 WASHINGTON BLVD. STAMFORD CT 06901 0 0 1 0 0001421162 Galen Management, LLC 680 WASHINGTON BLVD. STAMFORD CT 06901 0 0 1 0 0001034486 GALEN PARTNERS III L P C/O GALEN MANAGEMENT, L.L.C. 680 WASHINGTON BLVD. STAMFORD CT 06901 0 0 1 0 Common Stock 2013-06-04 4 S 0 22802 2.21 D 11822674 I See FN Common Stock 2013-06-05 4 S 0 6650 2.21 D 11816024 I See FN Common Stock 2013-06-06 4 S 0 10001 2.13 D 11806023 I See FN The shares were sold as follows: 20,831 by Galen Partners III, L.P. ("Galen III"), 1,885 by Galen Partners International III, L.P. ("Galen International") and 86 by Galen Employee Fund III, L.P. ("Employee Fund"). The shares were sold at prices between $2.20 and $2.25. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares are held as follows: 10,803,732 by Galen III, 974,440 by Galen International and 44,502 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein. The shares were sold as follows: 6,075 by Galen III, 550 by Galen International and 25 by Employee Fund. The shares were sold at prices between $2.20 and $2.245. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares are held as follows: 10,797,657 by Galen III, 973,890 by Galen International and 44,477 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein. The shares were sold as follows: 9,136 by Galen III, 827 by Galen International and 38 by Employee Fund. The shares were sold at prices between $2.11 and $2.15. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares are held as follows: 10,788,521 by Galen III, 973,063 by Galen International and 44,439 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein. /s/ David W. Jahns, Member of Claudius, L.L.C. 2013-06-07 /s/ David W. Jahns, Member of Claudius L.L.C., the General Partner of Galen Partners International III, L.P. 2013-06-07 /s/ David W. Jahns, Member Galen Management, L.L.C., the General Partner of Galen Employee Fund III, L.P. 2013-06-07 /s/ David W. Jahns, Member 2013-06-07 /s/ David W. Jahns, Member of Claudius, L.L.C., the General Partner of Galen Partners III, L.P. 2013-06-07